BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma & Biopharma Manufacturing

Univercells Tech and VectorBuilder announce partnership for optimized custom viral vector production

Agreement to encompass co-development and optimization of protocols for intensified and continuous viral vector production for cell and gene therapies and ...

July 07, 2021 | News

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

Sanofi to Focus on innovating mRNA vaccines beyond pandemic

Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate t...

June 30, 2021 | News

Evonik markets new advanced technology for sustainable pharmaceutical production

Evonik now offers ‘Chemistry in Water’, to enable classical organic reactions to be performed in water New technology allows drug manufactur...

June 30, 2021 | News

Cherwell reaches custom cleanroom product development milestone in its 50th year

Cherwell Laboratories, specialists in cleanroom microbiology solutions, announces in its 50th anniversary year that it has successfully develope...

June 29, 2021 | News

Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme

Yposkesi, a best-in-class Contract Development and Manufacturing Organization (CDMO) for companies developing cell and gene therapies, today announces the ...

June 29, 2021 | News

Körber to start Immunotech’s digital journey towards intelligent manufacturing

Körber and Immunotech Biopharm will implement Werum PAS-X MES in a greenfield cell & gene site in Beijing. This step is an important milestone to ...

June 29, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

June 24, 2021 | News

mRNA Vaccine Technology Holds Promise, but Faces Challenges

Numerous studies and statistics from national governments also suggest the data looks good regarding how the mRNA vaccines perform against emerging variant...

June 24, 2021 | Opinion

Coriolis Pharma Expands its ATMP Development Facilities

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical dr...

June 21, 2021 | News

Ampio Pharmaceuticals, Inc. to Join the Russell Index's

Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies...

June 21, 2021 | News

Manufacturing Strategies for mRNA Vaccines and Therapeutics

In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...

June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments

Novo Nordisk Plans Global Expansion With Amalgam Rx

Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform...

June 17, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

June 16, 2021 | News

Stay Connected